SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sai Life Sciences - Quaterly Results

14 May 2025 Evaluate
A decent increase of about 32.62% in the sales to Rs. 5670.06 millions was observed for the quarter ended March 2025. The sales figure stood at Rs. 4275.36 millions during the year-ago period.The company has announced a 46.23% increase in its profits to Rs . 899.35  millions for the  quarter ended March 2025 compared to Rs. 615.03 millions in the corresponding quarter in the previous year.OP of the company witnessed a marginal growth to 1637.18 millions from 1307.31 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 5670.06 4275.36 32.62 16420.48 14186.82 15.74 16420.48 14186.82 15.74
Other Income 98.19 41.90 134.34 373.35 293.32 27.28 373.35 293.32 27.28
PBIDT 1637.18 1307.31 25.23 4277.81 3159.42 35.40 4277.81 3159.42 35.40
Interest 91.58 194.17 -52.84 700.32 797.24 -12.16 700.32 797.24 -12.16
PBDT 1545.60 1113.14 38.85 3577.49 2362.18 51.45 3577.49 2362.18 51.45
Depreciation 340.95 279.99 21.77 1260.33 1072.13 17.55 1260.33 1072.13 17.55
PBT 1204.65 833.15 44.59 2317.16 1290.05 79.62 2317.16 1290.05 79.62
TAX 305.30 218.12 39.97 582.54 337.74 72.48 582.54 337.74 72.48
Deferred Tax 130.01 166.67 -22.00 244.38 258.05 -5.30 244.38 258.05 -5.30
PAT 899.35 615.03 46.23 1734.62 952.31 82.15 1734.62 952.31 82.15
Equity 208.41 180.50 15.46 208.41 180.50 15.46 208.41 180.50 15.46
PBIDTM(%) 28.87 30.58 -5.57 26.05 22.27 16.98 26.05 22.27 16.98

Sai Life Sciences Share Price

970.50 -1.35 (-0.14%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×